Excipients, raw materials and intermediates

Wave of acquisitions hits pharma industry this week

15-Jul-2021 By Jenni Spinner

The past several days have seen a relatively large number of industry acqusitions, with Lilly, Phillip Morris, WCG, CTI and others making notable buys.

Biden executive order could impact pharmaceutical industry

13-Jul-2021 By Jenni Spinner

US President Joe Biden singled out the pharmaceutical industry in his recently issued Executive Order on Promoting Competition in the American Economy.

DCAT Week 2021 to take on industry education, innovation

24-Jun-2021 By Jenni Spinner

The annual event (scheduled July 12-16 online) will feature educational sessions, presentations, and networking opportunities for drug manufacturing pros.

Hot-melt extrusion can improve bioavailability: Avomeen

14-Jun-2021 By Jenni Spinner

With bioavailability challenges a frequent frustration for drug developers, one research outfit suggests a technique that could reduce the headaches.

People on the Move: June 2021

02-Jun-2021 By Jenni Spinner

This month’s roundup of hires, acquisitions, anniversaries, and other announcements includes news from Premier Research, Cytel, ACG, and other companies.

Tech Innovations: May 2021

19-May-2021 By Jenni Spinner

This month’s roundup of new equipment, technology partnerships, and other news includes items from Ajinomoto, Elligo, Syneos, ACD/Labs and other companies.

Online HPAPI Summit takes on key pharma ingredients topics

19-May-2021 By Jenni Spinner

The virtual event (scheduled June 22-24) will feature presentations from Bayer, Merck, GSK, Novartis, Takeda, FDA, WHO, and other notable organizations.

Ampac announces $25m expansion of pharma manufacturing facility

19-May-2021 By Jenni Spinner

The company is enhancing its Virginia facility to add an east coast presence for its Analytical Labs division and enhance R&D for pharma ingredients.

Novasep expands in France, sees increasing customer demand for ADC manufacturing services

14-May-2021 By Jane Byrne

Novasep has announced a further expansion of its Highly Potent Active Pharmaceutical Ingredients (HPAPIs) manufacturing capabilities at its Le Mans, France site, saying the move strengthens its position as a leading CDMO for the production of innovative...

Could synthetic biology solutions fix supply chain challenges?

11-May-2021 By Jenni Spinner

An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes.

‘Cognitive’ supply chain approach boosts safety, efficiency: FourKites

21-Jan-2021 By Jenni Spinner

A leader from the supply-chain specialist explains vulnerabilities and challenges unique to pharma, and how professionals can safeguard and streamline.

Continuus lands $69.3m US drug manufacturing contract

21-Jan-2021 By Jenni Spinner

The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines for a range of conditions.

Lonza scientific team on the hunt for pharma fakery

13-Jan-2021 By Jenni Spinner

The company’s Forensic Chemistry Group comprises a collection of technical professionals using their respective talents to detect and thwart counterfeiting.

Pharmaceutical firms warming up to outsourcing: ReAgent

07-Jan-2021 By Jenni Spinner

A leader from the chemical manufacturing firm notes pharma companies are showing increased interest in contracting out their manufacturing functions.

Ingredients, innovation and a need for speed: what’s in store for 2021

23-Dec-2020 By Jenni Spinner

Three leaders from pharma ingredients and innovation firm Lonza share views on challenges and opportunities likely to face the industry in coming months.